Litigation promises to be much more lucrative than whatever it was NS8 pretended to be doing.
Burford Capital would like the Muddy Waters founder’s rebellious phase to end now.
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Last year proved a slow one for dealmaking in the life sciences space. But that didn’t stop two of the major legal players in it from consummating one themselves: In November, Arnold & Porter and Kaye Scholer agreed to merge, bringing together two formidable healthcare practices...
Why not predict pricing correctly, like a true Monegasque?
Hedge fund sues over being asked about its 9/11 and NFL concussion-based portfolio.
He's like the Charles Bronson of legal investment capital.
It’s time to know more about corporate venture capital because, unlike traditional venture or angel groups, there’s much less insight on corporate VCs and their practices.
If only the Pied Piper boys had known about litigation finance.
About a month ago, I discussed the venture capital landscape, and why litigation funders are attractive partners for VCs and VC-backed companies in need of resources to adequately defend their businesses. A similar, but distinct, phenomenon exists in private equity.